Cancer Research UK logo.
SearchDonate
  • Search

A trial of BI-1206 for lymphoma and leukaemia

Overview

Cancer types:

Blood cancers, Cell type, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Hodgkin lymphoma, Leukaemia, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)

Status:

Results

Phase:

Phase 1/2

Details

This trial looked at BI-1206 to treat B cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia.

The trial was supported by Cancer Research UK. It was open for people to join between 2016 and 2020. The team reported the results in 2021.

Recruitment start: 4 October 2016

Recruitment end: 27 March 2020

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Andrew Davies

Supported by

BioInvent International AB

Blood Cancer UK (used to be called Bloodwise)

Cancer Research UK (trial sponsor  - regulatory@cancer.org.uk)

Other information

The CRUK trial number is CRUKD/16/001.

There is more information about this trial on the clinicaltrials.gov website (NCT02933320):

BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia(link is external)

Last reviewed: 08 Mar 2023

CRUK internal database number: 14371

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.